Double-Blind, Randomized Study of the Efficacy and Safety of Oral Pharmacokinetically Enhanced Amoxicillin-Clavulanate (2,000/125 Milligrams) versus Those of Amoxicillin-Clavulanate (875/125 Milligrams), Both Given Twice Daily for 7 Days, in Treatment of Bacterial Community-Acquired Pneumonia in Adults

• Autores: T. M. File, E. Berkowitz
• Localización: Antimicrobial agents and chemotherapy, ISSN 0066-4804, Vol. 48, Nº. 9, 2004, págs. 3323-3331
• Idioma: inglés
• Texto completo no disponible (Saber más ...)